Your browser doesn't support javascript.
loading
Delayed Sputum Culture Conversion in Tuberculosis-Human Immunodeficiency Virus-Coinfected Patients With Low Isoniazid and Rifampicin Concentrations.
Sekaggya-Wiltshire, Christine; von Braun, Amrei; Lamorde, Mohammed; Ledergerber, Bruno; Buzibye, Allan; Henning, Lars; Musaazi, Joseph; Gutteck, Ursula; Denti, Paolo; de Kock, Miné; Jetter, Alexander; Byakika-Kibwika, Pauline; Eberhard, Nadia; Matovu, Joshua; Joloba, Moses; Muller, Daniel; Manabe, Yukari C; Kamya, Moses R; Corti, Natascia; Kambugu, Andrew; Castelnuovo, Barbara; Fehr, Jan S.
Afiliação
  • Sekaggya-Wiltshire C; Infectious Diseases Institute, College of Health Sciences, Makerere University, Kampala, Uganda.
  • von Braun A; Division of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, University of Zurich, Switzerland.
  • Lamorde M; Infectious Diseases Institute, College of Health Sciences, Makerere University, Kampala, Uganda.
  • Ledergerber B; Division of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, University of Zurich, Switzerland.
  • Buzibye A; Infectious Diseases Institute, College of Health Sciences, Makerere University, Kampala, Uganda.
  • Henning L; Division of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, University of Zurich, Switzerland.
  • Musaazi J; Division of Tropical Health and Medicine, James Cook University, Queensland, Australia.
  • Gutteck U; Infectious Diseases Institute, College of Health Sciences, Makerere University, Kampala, Uganda.
  • Denti P; Department of Clinical Chemistry, University Hospital Zurich, University of Zurich, Switzerland.
  • de Kock M; Division of Clinical Pharmacology, Department of Medicine, University of Cape Town, South Africa.
  • Jetter A; Division of Clinical Pharmacology, Department of Medicine, University of Cape Town, South Africa.
  • Byakika-Kibwika P; Department of Clinical Pharmacology and Toxicology, University Hospital Zurich, University of Zurich, Switzerland.
  • Eberhard N; Infectious Diseases Institute, College of Health Sciences, Makerere University, Kampala, Uganda.
  • Matovu J; School of Medicine, Makerere University, Kampala, Uganda.
  • Joloba M; Division of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, University of Zurich, Switzerland.
  • Muller D; Infectious Diseases Institute, College of Health Sciences, Makerere University, Kampala, Uganda.
  • Manabe YC; School of Biomedical Sciences, College of Health Sciences, Makerere University, Kampala, Uganda.
  • Kamya MR; Department of Clinical Chemistry, University Hospital Zurich, University of Zurich, Switzerland.
  • Corti N; Division of Infectious Diseases, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore.
  • Kambugu A; School of Medicine, Makerere University, Kampala, Uganda.
  • Castelnuovo B; Department of Clinical Pharmacology and Toxicology, University Hospital Zurich, University of Zurich, Switzerland.
  • Fehr JS; Infectious Diseases Institute, College of Health Sciences, Makerere University, Kampala, Uganda.
Clin Infect Dis ; 67(5): 708-716, 2018 08 16.
Article em En | MEDLINE | ID: mdl-29514175
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 2_ODS3 / 3_ND Base de dados: MEDLINE Assunto principal: Rifampina / Escarro / Tuberculose Pulmonar / Infecções por HIV / Isoniazida / Antituberculosos Tipo de estudo: Etiology_studies / Observational_studies / Risk_factors_studies Limite: Adult / Female / Humans / Male País/Região como assunto: Africa Idioma: En Revista: Clin Infect Dis Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 2_ODS3 / 3_ND Base de dados: MEDLINE Assunto principal: Rifampina / Escarro / Tuberculose Pulmonar / Infecções por HIV / Isoniazida / Antituberculosos Tipo de estudo: Etiology_studies / Observational_studies / Risk_factors_studies Limite: Adult / Female / Humans / Male País/Região como assunto: Africa Idioma: En Revista: Clin Infect Dis Ano de publicação: 2018 Tipo de documento: Article